Email this article 
CLINICAL SIGNIFICANCE OF INSULIN RESISTANCE SYNDROME IN DEVELOPMENT OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH PRIMARY GOUT
- Authors: Kushnarenko N.N.1, Govorin A.V.1, Shcherbakova O.A.1, Sotnikova S.G.1, Ivanitskaya O.V.1
-
Affiliations:
- Chita State Medical Academy Ministry of Healthcare and Social development of Russia, Chita, Russia
- Issue: Vol 67, No 2 (2012)
- Pages: 60-63
- Section: ENDOCRINOLOGY: CURRENT ISSUES
- Published: 22.02.2012
- URL: https://vestnikramn.spr-journal.ru/jour/article/view/346
- DOI: https://doi.org/10.15690/vramn.v67i2.123
- ID: 346
Cite item
Full Text
Abstract
Keywords
About the authors
N. N. Kushnarenko
Chita State Medical Academy Ministry of Healthcare and Social development of Russia, Chita, Russia
Author for correspondence.
Email: pochta@medacadem.chita.ru
кандидат медицинских наук, заведующая кафедрой внутренних болезней стома- тологического и педиатрического факультетов Читинской государственной медицинской академии. Россия
A. V. Govorin
Chita State Medical Academy Ministry of Healthcare and Social development of Russia, Chita, Russia
Email: pochta@medacadem.chita.ru
доктор медицинских наук, профессор, заслуженный врач РФ, ректор ГОУ ВПО Читинской государственной медицинской академии, заведующий кафедрой факультетской терапии. Россия
O. A. Shcherbakova
Chita State Medical Academy Ministry of Healthcare and Social development of Russia, Chita, Russia
Email: pochta@medacadem.chita.ru
Россия
S. G. Sotnikova
Chita State Medical Academy Ministry of Healthcare and Social development of Russia, Chita, Russia
Email: pochta@medacadem.chita.ru
Россия
O. V. Ivanitskaya
Chita State Medical Academy Ministry of Healthcare and Social development of Russia, Chita, Russia
Email: pochta@medacadem.chita.ru
Россия
References
- Namakanov B.A., Rasulov M.M. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular therapy and prophylaxis. 2005; 4 (6): 98−101.
- Trusov V.V., Filimonov M.A., Aksenov K.V. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular therapy and prophylaxis. 2005; 4 (6): 62−66.
- Petrischev N.N. Disfunktsiya endoteliya: prichiny, mekhanizmy, farmakologicheskaya korrektsiya [Endothelial Dysfunction: Etiology, Mechanisms, Pharmacological Correction]. St. Petersburg, SPbGMU, 2003. 184 p.
- Furchgott R.F, Vanhoutte P.M. Еndothelium-derived relaxing and contracting factors. FASEB J. 1989; 3: 2007−2018.
- Rackley C.E. Endothelial UpToDate. 2002; 10. Available at: http://www.uptodate.com
- Kanellis J., Kang D.H. Uric acid as a mediator of endothelial dysfunction, inflammation and vascular diseas. Semin. Nephrol. 2005; 25: 39−42.
- Lapkina N.A., Baranov A.A., Barskova V.G. et al. Ter. arhiv = Therapeutic archive. 2005; 6: 62−65.
- Laakso M., Sarlund H., Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subject with varying degrees of glucose tolerance. Arteriosclerosis. 1990; 10: 223−231.
- Wallace К.L., Riedel A.A., Joseph-Ridge N. et al. Increasing prevalence of gout and hyperuricemia over 10 years among older adult in a managed care population. J. Rheumatol. 2004; 31: 1582−1587.
- Ivanova O.V., Rogoza A.N., Balahonova T.V. et al. Kardiologiya = Cardiology. 1998; 3: 37−41.
- Hollenbeck C.B., Chen N., Chen Y.-D. I., Reaven G.М. Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes. 1984; 33: 460−463.
- Rojtberg G.E. Metabolicheskii sindrom [Metabolic Syndrome]. Moscow, 2007.
- Zatejschikova A.A., Zatejschikov D.A. Kardiologiya = Cardiology. 1998; 9: 68−76.
- ESH-ESC Guidelines Committee. ESH-ESC guidelines for the management of arterial hypertension. J. Hypertens. 2007; 21: 1011−1053.
- Vogel R.A. Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin. Cardiol. 1997; 20: 426−432.
Supplementary files
